2026 Marina Caskey: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	69	2470	2269	1181	1076	129	25697

Overview

Marina Caskey is affiliated with Rockefeller University in the United States and has contributed extensively to the fields of medicine and immunology and microbiology. Their research focuses on infectious diseases, virology, immunology, molecular biology, and imaging techniques related to radiology and nuclear medicine.

Much of Caskey's work has centered on the study of SARS-CoV-2 and COVID-19, with significant publications addressing antibody responses, vaccine-elicited immunity, and viral variants. Additionally, they have contributed to HIV research, including drug development and clinical interventions.

Key topics covered in their research include:

SARS-CoV-2 and COVID-19 Research
HIV Research and Treatment
HIV/AIDS drug development and treatment
COVID-19 Clinical Research Studies
HIV/AIDS Research and Interventions
Monoclonal and Polyclonal Antibodies Research
SARS-CoV-2 detection and testing

Their frequent co-authors reflect a collaborative approach in immunology and virology, including Michel C. Nussenzweig, Christian Gaebler, Frauke Muecksch, Théodora Hatziioannou, and Paul D. Bieniasz.

Marina Caskey's publications appear regularly in notable scientific venues. The venues where they have most frequently published include:

bioRxiv (Cold Spring Harbor Laboratory)
Nature
The Journal of Experimental Medicine
Nature Communications
Nature Medicine

Among their recent papers are:

Convergent antibody responses to SARS-CoV-2 in convalescent individuals, 2020, Nature
Evolution of antibody immunity to SARS-CoV-2, 2021, Nature
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants, 2021, Nature
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants, 2020, eLife
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies, 2020, Cell

Best Publications

Convergent antibody responses to SARS-CoV-2 in convalescent individuals.

Davide F. Robbiani;Davide F. Robbiani;Christian Gaebler;Frauke Muecksch;Julio C.C. Lorenzi

2548
Citations
Evolution of antibody immunity to SARS-CoV-2.

Christian Gaebler;Zijun Wang;Julio C. C. Lorenzi;Frauke Muecksch

1656
Citations
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.

Yiska Weisblum;Fabian Schmidt;Fengwen Zhang;Justin DaSilva

1441
Citations
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.

Zijun Wang;Fabian Schmidt;Yiska Weisblum;Frauke Muecksch

1434
Citations
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.

Christopher O. Barnes;Anthony P. West;Kathryn E. Huey-Tubman;Magnus A.G. Hoffmann

877
Citations
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

Marina Caskey;Florian Klein;Julio C. C. Lorenzi;Michael S. Seaman

855
Citations
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant.

M. Paula Longhi;Christine Trumpfheller;Juliana Idoyaga;Marina Caskey

759
Citations
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.

Zijun Wang;Frauke Muecksch;Dennis Schaefer-Babajew;Shlomo Finkin

717
Citations
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.

Fabian Schmidt;Yiska Weisblum;Frauke Muecksch;Hans-Heinrich Hoffmann

665
Citations
Combination therapy with anti-HIV-1 antibodies maintains viral suppression

Pilar Mendoza;Henning Gruell;Lilian Nogueira;Joy A. Pai

537
Citations
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

Johannes F. Scheid;Johannes F. Scheid;Joshua A. Horwitz;Yotam Bar-On;Edward F. Kreider

520
Citations
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

Marina Caskey;Till Schoofs;Henning Gruell;Allison Settler

517
Citations
HIV-1 Integration Landscape during Latent and Active Infection

Lillian B. Cohn;Israel T. Silva;Israel T. Silva;Thiago Y. Oliveira;Rafael A. Rosales

496
Citations
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost

Unknown

486
Citations
Enhanced SARS-CoV-2 neutralization by dimeric IgA.

Zijun Wang;Julio C. C. Lorenzi;Frauke Muecksch;Shlomo Finkin

475
Citations
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.

Allison J. Greaney;Tyler N. Starr;Tyler N. Starr;Christopher O. Barnes;Yiska Weisblum

437
Citations
Enhanced clearance of HIV-1–infected cells by broadly neutralizing antibodies against HIV-1 in vivo

Ching-Lan Lu;Ching-Lan Lu;Dariusz K. Murakowski;Stylianos Bournazos;Till Schoofs

379
Citations
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

Davide F. Robbiani;Leonia Bozzacco;Jennifer R. Keeffe;Ricardo Khouri

364
Citations
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1

Till Schoofs;Florian Klein;Florian Klein;Florian Klein;Malte Braunschweig;Malte Braunschweig;Edward F. Kreider

356
Citations
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

Steven G. Deeks;Nancie Archin;Paula Cannon;Simon Collins

354
Citations
The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine

Christine Trumpfheller;Marina Caskey;Godwin Nchinda;Maria Paula Longhi

352
Citations
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans

Marina Caskey;François Lefebvre;Abdelali Filali-Mouhim;Mark J. Cameron

338
Citations
Evolution of Antibody Immunity to SARS-CoV-2

Christian Gaebler;Zijun Wang;Julio C C Lorenzi;Frauke Muecksch

151
Citations

Frequent Co-Authors

Michel C. Nussenzweig Rockefeller University

Paul D. Bieniasz Rockefeller University

Thiago Y. Oliveira Rockefeller University

Anna Gazumyan Rockefeller University

Theodora Hatziioannou Rockefeller University

Davide F. Robbiani Universita della Svizzera Italiana

Arlene Hurley Rockefeller University

Victor A. Ramos University of Buenos Aires

Mila Jankovic Rockefeller University

Pamela J. Bjorkman California Institute of Technology

External Links

Wikipedia of Marina Caskey Personal website of Marina Caskey

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your knowledge through related online degrees can open diverse career opportunities in healthcare. Many students without prior medical background consider online nursing programs for non nurses, a practical pathway to enter the nursing field efficiently and build a strong foundation in patient care alongside immunological expertise.

Accelerated programs are ideal for motivated learners looking to fast-track their careers. Exploring the easiest accelerated nursing programs can help prospective students find options that balance accessibility with rigorous training.

For those seeking more hands-on roles within healthcare, which lpn programs are easiest to get into provides insight into practical nursing licenses that can complement immunology knowledge by offering direct patient interaction experiences.

Finally, advancing to specialized roles is feasible through easiest online nurse practitioner programs, designed to equip students with advanced clinical skills, including aspects relevant to immunology and patient immune response management.